| Adebrelimab studied in …STUDIED_INderived148 of 148show fewer |
|---|
| → studied in | NCT06618664Phase 3 · recruiting A Clinical Study of SHR-8068 Combined With Adebrelimab and Bevacizumab Versus Sintilimab Combined With Bevacizumab for the Treatment of Advanced Hepatocellular Carcinoma (KYLIN-02) · 148 trials list this drug (123 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07836543Phase 2 · not yet recruiting Trastuzumab Rezetecan and Adebrelimab, Alone or in Combination, After Chemoradiotherapy for HER2-Altered Unresectable Stage III Lung Cancer · 148 trials list this drug (123 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07583550Phase 2 · recruiting Low-dose Thoracic Radiotherapy Followed by Adebrelimab Plus Chemotherapy, and Then Sequential Maintenance Therapy With Adebrelimab for Extensive-stage Small Cell Lung Cancer · 148 trials list this drug (123 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07827053Phase 2 · not yet recruiting Clinical Study of Radiotherapy Combined With Adebrelimab and NALIRIFOX for Conversion Therapy in Locally Advanced Pancreatic Cancer · 148 trials list this drug (123 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07824882Phase 2 · not yet recruiting A Phase II Study of HS-20093 Injection Combined With Adebrelimab Versus HS-20093 Injection in Previously Treated Patients With Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer Without Actionable Genomic Alterations · 148 trials list this drug (123 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07822542Phase 3 · not yet recruiting A Study Evaluating HS-10370 Plus Platinum-based Doublet Chemotherapy With or Without Adebrelimab vs. Tislelizumab Plus Chemotherapy as First-Line Therapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer · 148 trials list this drug (123 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06483282Phase 2 · recruiting A Study of Adebrelimab Combined With Apatinib Mesylate and Chemotherapy for Neoadjuvant Therapy and Biomarker Analysis in Limited-stage Small Cell Lung Cancer · 148 trials list this drug (123 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06840002Phase 1/Phase 2 · recruiting A Clinical Study of SHR-A1811 Combined With Chemotherapy for Platinum Sensitive Recurrent Ovarian Cancer · 148 trials list this drug (123 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07811375Phase 2 · not yet recruiting Perioperative Adebrelimab for Locally Advanced Cervical Cancer · 148 trials list this drug (123 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07679360Phase 3 · recruiting A Study of Trastuzumab Rezetecan in Combination With Adebrelimab Versus Investigator's Choice of Therapy in Subjects With Residual Triple Negative Breast Cancer · 148 trials list this drug (123 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07798947Phase 2 · not yet recruiting A Phase II Clinical Study of SHR-7787 Injection Combined With SHR-1316 Injection in Patients With LS-SCLC · 148 trials list this drug (123 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07736612Phase 1/Phase 2 · not yet recruiting A Pan-RAS Inhibitor in Combination With Anti-Tumor Therapy in Participants With Advanced Pancreatic Cancer · 148 trials list this drug (123 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07789379Phase 2 · not yet recruiting Adebrelimab Plus Temozolomide ± Hyperbaric Oxygen for Primary Glioblastoma · 148 trials list this drug (123 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07778732Phase 2 · not yet recruiting Adebrelimab Combined With Dalpiciclib Isethionate Plus Chemotherapy for Neoadjuvant Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma · 148 trials list this drug (123 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07780721Phase 2 · not yet recruiting Study of Adebrelimab Combined With Thymalfasin and Chemotherapy for Neoadjuvant Treatment of Esophageal Cancer · 148 trials list this drug (123 active) | — | — | Malignant Esophageal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07770113Phase 2 · recruiting A Random, Non-controlled, Open Clinical Study of Apatinib Mesylate Combined With Albumin-bound Paclitaxel ± Adebrelimab in Treating Advanced Second-line Gastric Cancer · 148 trials list this drug (123 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07071714Phase 2 · active not recruiting A Phase II Study of SHR-8068 Injection in Combination With Anti-tumor Therapies in Colorectal Cancer · 148 trials list this drug (123 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07733830Phase 2 · recruiting Comparing ICI Followed By CCRT And CCRT Followed By Immunotherapy In Unresectable LA-ESCC · 148 trials list this drug (123 active) | — | — | Malignant Esophageal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07731828Phase 2 · recruiting Neoadjuvant Short-course Hypofractionated Radiotherapy Plus Adebrelimab and Platinum Chemotherapy in Locally Advanced Cervical Cancer: A Single-arm Phase II Trial · 148 trials list this drug (123 active) | — | — | Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07718490Phase 2 · recruiting Immunotheray Combined With Simvastatin and Target Therapy and Chemotharepy for Advanced Colorectal Cancer · 148 trials list this drug (123 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07059221Phase 1/Phase 2 · recruiting A Trial of SHR-A2102 With Adebrelimab With or Without Other Anti-tumor Therapies in Recurrent/MetastaticHead and Neck Squamous Cell Carcinoma Cancer · 148 trials list this drug (123 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07704177Phase 2 · recruiting Phase II Study of Trastuzumab Rezetecan Combined With Adebrelimab and Lenvatinib in Advanced HER2-Positive/Low-Expression Biliary Tract Cancer · 148 trials list this drug (123 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06433609Phase 2 · recruiting Study of ADCs Combined With Adebrelimab in HER2-negative Advanced Breast Cancer · 148 trials list this drug (123 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07682272Phase 2 · not yet recruiting A Trial of SHR-8068 Combined With Adebrelimab and Apatinib in Perioperative Treatment of Resectable Hepatocellular Carcinoma · 148 trials list this drug (123 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07670273Phase 2 · recruiting Phase II Study of Trastuzumab Rezetecan Combined With Adebrelimab and Lenvatinib as First-Line Therapy for Advanced HER2-Positive/HER2-Low Biliary Tract Cancer · 148 trials list this drug (123 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07668453Phase 2 · recruiting An Open-label, Single-arm, Multicenter Exploratory Study of Adebrelimab Combined With Gemcitabine and Albumin-bound Paclitaxel as First-line Treatment for Biliary Tract Malignancies · 148 trials list this drug (123 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07638436Phase 2 · recruiting Adebrelimab Combined With Neoadjuvant Chemotherapy in Borderline Resectable Locally Advanced Esophageal Squamous Cell Carcinoma · 148 trials list this drug (123 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07640048recruiting Adjuvant Therapy for High-Risk Intrahepatic Cholangiocarcinoma: A Real-World Study · 148 trials list this drug (123 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06339619Phase 2 · recruiting Combination Immunotherapy of Adebrelimab With Apatinib and Tegafur, Gimeracil and Oteracil Potassium Capsules for Immune Rechallenge Therapy in Esophageal Squamous Cell Carcinoma · 148 trials list this drug (123 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06405061Phase 2 · suspended Evaluation of Effectiveness and Safety of HAIC in Combination With Adebrelimab and Bevacizumab for Potentially Resectable Hepatocellular Carcinoma · 148 trials list this drug (123 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06465563Phase 2 · active not recruiting SHR-8068 in Combination With Adebrelimab, Bevacizumab, and Platinum-Based Chemotherapy as First-line Treatment in Patients With Advanced Biliary Tract Cancer · 148 trials list this drug (123 active) | — | — | Malignant Biliary Tract Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05582499Phase 2 · recruiting Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy · 148 trials list this drug (123 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm,Early Stage Breast Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06427239Phase 1/Phase 2 · recruiting Exploratory Clinical Study of HRS-4642 Combined With Adebrelimab in the Treatment of Advanced Pancreatic Ductal Adenocarcinoma · 148 trials list this drug (123 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07569679Phase 2 · recruiting Alternating HAIC and Systemic Chemotherapy With or Without Adebrelimab and Apatinib for Unresectable Biliary Tract Cancer · 148 trials list this drug (123 active) | — | — | Malignant Biliary Tract Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07561775Phase 2 · not yet recruiting Adebrelimab Plus S-1 for Resected Cholangiocarcinoma · 148 trials list this drug (123 active) | — | — | Malignant Biliary Tract Neoplasm,Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07241793Phase 2 · recruiting Phase II Study of Trastuzumab Rezetecan or in Combination With Adebrelimab in HER2-Expressing Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC) · 148 trials list this drug (123 active) | — | — | Transitional Cell Carcinoma,Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07543783Phase 2 · not yet recruiting Efficacy and Safety of Low-dose Bevacizumab Plus Adebrelimab Combined With Transarterial Chemoembolization Followed by Hepatic Arterial Infusion Chemotherapy (TACE-HAIC) as First-line Treatment for Unresectable Hepatocellular Carcinoma: A Single-arm Phase 2 Trial · 148 trials list this drug (123 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07554768Phase 2 · not yet recruiting Neoadjuvant Radio-immunotherapy Versus Immunotherapy Alone for Locally Advanced HNSCC · 148 trials list this drug (123 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07353684Phase 2 · recruiting Adebrelimab Plus Apatinib Combined With SOX Regimen as Conversion Therapy for Gastric Cancer · 148 trials list this drug (123 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07392541Phase 1/Phase 2 · recruiting Adebrelimab Combined With Gemcitabine, Cisplatin, and Simvastatin for Advanced Biliary Tract Cancer · 148 trials list this drug (123 active) | — | — | Biliary Tract Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07466927Phase 2 · not yet recruiting Study of Multi-mode Thermal Therapy Combined With Immunotherapy In Patients With HER2-negative Breast Cancer With Liver Metastases · 148 trials list this drug (123 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07437898Phase 2 · recruiting Neoadjuvant Adebrelimab Plus Chemotherapy for Esophageal Cancer: A Clinical Study · 148 trials list this drug (123 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07434518recruiting A Real-World Study Evaluating the Efficacy and Safety of Adebrelimab in Patients With Advanced SCLC · 148 trials list this drug (123 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07398560Phase 2 · not yet recruiting Adebrelimab Combined With Oral Etoposide for Elderly Patients and Patients With Poor Performance Status in Small Cell Lung Cancer: An Exploratory Clinical Study · 148 trials list this drug (123 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06610734Phase 2 · recruiting Multicenter, Phase II Randomized Controlled Study of Adebrelimab Combined With Chemotherapy and Concurrent Low-Dose Radiotherapy (LDRT) for the Treatment of Extensive-Stage Small Cell Lung Cancer (SCLC) · 148 trials list this drug (123 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07388095NA · not yet recruiting Adebrelimab Neoadjuvant Treatment for Resectable ESCC · 148 trials list this drug (123 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07229625Phase 3 · recruiting A Phase III Study of SHR-8068 in Combination With Adebrelimab and Platinum-Containing Chemotherapy Versus Durvalumab in Combination With Platinum-Containing Chemotherapy as First-line Treatment for Advanced Biliary Tract Cancer (BTC) · 148 trials list this drug (123 active) | — | — | Malignant Biliary Tract Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07266025Phase 2 · not yet recruiting Adebrelimab Combined With Induction Chemotherapy or SHR-8068 for Mismatch Repair-Deficient/Microsatellite Instability-High (dMMR/MSI-H) Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma：A Randomized, Non-comparative Phase 2 Study · 148 trials list this drug (123 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07357532Phase 2 · not yet recruiting Exploration of Treatment Strategies After Concurrent Chemoradiotherapy for LS-SCLC Guided by MRD · 148 trials list this drug (123 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07110571Phase 2 · recruiting A Trial of Adebrelimab Plus (SHR-A1811/SHR-A1904 With Chemotherapy) or SHR-8068 as Treatment for Gastric/GEJ Cancer · 148 trials list this drug (123 active) | — | — | Gastric Neoplasm,Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07317778Phase 2 · not yet recruiting Chemotherapy With or Without Adebrelimab and T-DXh as Neoadjuvant Therapy for HR+/HER2 Low Early Stage Breast Cancer · 148 trials list this drug (123 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07309185Phase 2 · recruiting Adebrelimab Combined With Famitinib and Irinotecan in Advanced Gastric Cancer After Failure of First-Line Therapy · 148 trials list this drug (123 active) | — | — | Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06512051Phase 1/Phase 2 · recruiting A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Non-small Cell Lung Cancer · 148 trials list this drug (123 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06091124Phase 2 · recruiting Neoadjuvant Adebrelimab Plus Etoposide and Cisplatin in Neuroendocrine Bladder Carcinoma · 148 trials list this drug (123 active) | — | — | Bladder Neoplasm,Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05076682Phase 2 · recruiting Reverse Triple Negative Immune Resistant Breast Cancer · 148 trials list this drug (123 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06703177Phase 1/Phase 2 · recruiting A Study of SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With Solid Tumors · 148 trials list this drug (123 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07229729Phase 2 · recruiting A Study of SHR-A2102 in Combination With Other Anti-tumor Therapies for Resectable Non-small Cell Lung Cancer · 148 trials list this drug (123 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07238569Phase 3 · not yet recruiting Phase III Trial of EBV-DNA-Guided Adaptive Immunotherapy for Advanced Nasopharyngeal Carcinoma · 148 trials list this drug (123 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06177522Phase 2 · not yet recruiting Adebrelimab Combined With Chemotherapy for Neoadjuvant Therapy in Resectable Pancreatic Cancer · 148 trials list this drug (123 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07230301Phase 2 · not yet recruiting Adebrelimab Infusion Plus Standard Care for Pancreatic Cancer With Pleural or Peritoneal Effusions · 148 trials list this drug (123 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06385678Phase 1/Phase 2 · active not recruiting A Study of HRS-4642 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation · 148 trials list this drug (123 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07173244not yet recruiting A Real-world Study of Adebrelimab-based Combination Regimens in the Treatment of Advanced Solid Tumors · 148 trials list this drug (123 active) | — | — | Malignant Digestive System Neoplasm,Lung Non-Small Cell Carcinoma,Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07069270Phase 2 · not yet recruiting A Study on the First-line Treatment of Small Cell Lung Cancer With Adebrelimab and Vunakizumab and Chemotherapy · 148 trials list this drug (123 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07061210Phase 2 · not yet recruiting An Explorative Study of HRS-2189 Combined With Adebrelimab and BP102 for Metastatic Colorectal Cancer · 148 trials list this drug (123 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07055841Phase 2 · recruiting Single-Arm Exploratory Study of PD-L1 Antibody Plus Neoadjuvant Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma · 148 trials list this drug (123 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06893887NA · recruiting Individualized Comprehensive Treatment for Advanced Hepatocellular Carcinoma · 148 trials list this drug (123 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04400188Phase 1/Phase 2 · completed A Study of Fluzoparib (SHR-3162) and Temozolomide With or Without SHR-1316 in Treating Patients With Replapsed Small Cell Lung Cancer · 148 trials list this drug (123 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07041437Phase 2 · not yet recruiting Study of SHR-A2102 Combined Other Antitumor Drugs in Advanced Breast Cancer · 148 trials list this drug (123 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07035392Phase 2 · not yet recruiting Adebrelimab + Chemotherapy as Neoadjuvant Therapy for Resectable NSCLC · 148 trials list this drug (123 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07031154Phase 2 · not yet recruiting A Single-arm, Multicenter, Prospective Clinical Study of Adebrelimab Combined With Apatinib Neoadjuvant Therapy for Resectable Non-small Cell Lung Cancer · 148 trials list this drug (123 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06277791Phase 2 · recruiting The Combination of Adebrelimab and TP Regimen for Neoadjuvant Therapy in Patients With Stage IVB Oral Squamous Cell Carcinoma · 148 trials list this drug (123 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06963502Phase 1 · not yet recruiting A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Patients With Advanced Solid Tumors · 148 trials list this drug (123 active) | — | — | Solid Neoplasm,Lung Non-Small Cell Carcinoma,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06914050Phase 2 · not yet recruiting Hypofractionated Radiotherapy Followed by Chemo-immunotherapy Induction Therapy · 148 trials list this drug (123 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06754930Phase 1/Phase 2 · recruiting A Study of SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With NSCLC · 148 trials list this drug (123 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06916975Phase 2 · not yet recruiting Adebrelimab Combined With AG Regimen in Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer · 148 trials list this drug (123 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06881017Phase 2 · not yet recruiting Establishment of Precision Targeted Therapy Strategies for Advanced Gastric Cancer Based on Novel Molecular Subtyping · 148 trials list this drug (123 active) | — | — | Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06778031Phase 2 · recruiting A Clinical Study of SHR-A1811 in the Treatment of HER2-positive Locally Advanced or Metastatic Biliary Tract Cancer · 148 trials list this drug (123 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06208462Phase 2 · recruiting Neoadjuvant Therapy of HAIC（GEMOX） Combined With Adebrelimab and Lenvatinib for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors · 148 trials list this drug (123 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06853678NA · recruiting Second-line Immunotherapy for ES-SCLC · 148 trials list this drug (123 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06842472Phase 2 · not yet recruiting PD-L1 Inhibitor + RT ± Ursodeoxycholic Acid in Recurrent/Metastatic HER2-Neg Breast Cancer · 148 trials list this drug (123 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06282445Phase 2 · recruiting Efficacy and Safety of Chemotherapy With XELOX (Oxaliplatin + Capecitabine) and Bevacizumab in Combination With Adebrelimab in First-line Treatment of Microsatellite Stable (MSS) Initially Unresectable Metastatic Colorectal Cancer · 148 trials list this drug (123 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06786312Phase 2 · not yet recruiting A Single-arm, Multicenter, Prospective Phase II Clinical Study of Apatinib in Combination With Adebrelimab and EC Regimen in the First-line Treatment of Extensive Small Cell Lung Cancer · 148 trials list this drug (123 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06349889Phase 2 · recruiting Adebrelimab and Chemoradiotherapy in High-risk LANPC · 148 trials list this drug (123 active) | — | — | Malignant Nasopharyngeal Neoplasm,Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06776770Phase 1/Phase 2 · recruiting A Phase Ib/II Study of Adebrelimab in Combination with Capecitabine and Oxaliplatin in Cancer · 148 trials list this drug (123 active) | — | — | Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06480864NA · recruiting Adebrelimab Plus Apatinib for Maintenance Therapy of Extensive Stage Small Cell Lung Cancer · 148 trials list this drug (123 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06749730Phase 2 · recruiting Adebrelimab Combined with Apatinib and Gemcitabine and Cisplatin (GP) First-line Treatment for Unresectable Biliary Tract Carcinoma · 148 trials list this drug (123 active) | — | — | Biliary Tract Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06237257Phase 2 · unknown A Study of Chemoradiotherapy With SHR-1316 For Treatment of Locally Advanced Cervical Cancer · 148 trials list this drug (123 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06470672Phase 2 · unknown Study of SHR-A1921 Combined Adebrelimab in HR-positive, HER2-negative Advanced Breast Cancer · 148 trials list this drug (123 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06735508early Phase 1 · not yet recruiting MRNA Neoantigen Vaccine in Non-Small Cell Lung Cancer · 148 trials list this drug (123 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06418594Phase 2 · recruiting Adebrelimab Plus Apatinib and Etoposide for the Treatment of HER2-Negative Breast Cancer Brain Metastasis · 148 trials list this drug (123 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06699576Phase 1 · not yet recruiting ARTEMIS-103: Phase 1b Study of HS-20093 Combinations in Patients with Bone and Soft Tissue Sarcoma. · 148 trials list this drug (123 active) | — | — | Osteosarcoma,Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06639347Phase 1/Phase 2 · recruiting A Trial of SHR-A2102 With Antitumor Therapy in Advanced Urothelial Carcinoma · 148 trials list this drug (123 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06692491Phase 2 · not yet recruiting Study of Precision Treatment for Rare Tumours in China Guided by PDO and NGS · 148 trials list this drug (123 active) | — | — | Rare Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06672133Phase 3 · not yet recruiting Adebrelimab Combined with Chemotherapy and Thoracic Radiotherapy for First-line Treatment of ES-SCLC · 148 trials list this drug (123 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04516681Phase 3 · recruiting Combination of IV Ascorbic Acid and Adebrelimab in Metastatic Colorectal Cancer · 148 trials list this drug (123 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06648525Phase 2 · not yet recruiting Adebrelimab Combined with Irinotecan Liposomes, 5-FU, CF ± Lenvatinib As First-line Treatment for Advanced ICC · 148 trials list this drug (123 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06510660Phase 2 · recruiting Adebrelimab ±Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Unresectable Locally Advanced ESCC · 148 trials list this drug (123 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06592625Phase 2 · not yet recruiting Neoadjuvant SHR-A1811 Plus Adebrelimab in HR Negative/Low & HER2 Low Breast Cancer Patients · 148 trials list this drug (123 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06594874Phase 1 · not yet recruiting A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Participants with KRAS G12C Mutation Advanced Solid Tumors · 148 trials list this drug (123 active) | — | — | Solid Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06599775Phase 2 · not yet recruiting Study of Adebrelimab With Chemotherapy, Endoscopy and Sequential Chemoradiotherapy In Inoperable Esophageal Cancer · 148 trials list this drug (123 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06475326Phase 2 · unknown Adebrelimab in Combination With NALIRIFOX in Locally Advanced Pancreatic Cancer · 148 trials list this drug (123 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06537505Phase 2 · not yet recruiting A Study of Microwave Ablation Combined With Immunotherapy ± Anti-angiogenic Drugs in the Treatment of Solid Tumors · 148 trials list this drug (123 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06531278Phase 2 · recruiting Adebelimab Combined With Irinotecan Liposomal Injection, Oxaliplatin, Fluorouracil and Calcium Folinate Are Used in the First-line Treatment of Pancreatic Cancer Liver Metastasis Efficacy and Safety · 148 trials list this drug (123 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04303988Phase 2 · unknown A Phase II Study of Triple-negative Breast Cancer Brain Metastases. · 148 trials list this drug (123 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06332170Phase 1 · recruiting ARTEMIS-101: A Study of HS-20093 Combinations in Patients With Advanced Solid Tumors · 148 trials list this drug (123 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06336707Phase 1 · recruiting HS-20089 Combination Treatment in Subjects With Advanced Solid Tumors · 148 trials list this drug (123 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06508229Phase 2 · not yet recruiting Adebrelimab Combined With Albumin Paclitaxel and Nedaplatin as Neoadjuvant Therapy for Locally Advanced Resectable ESCC · 148 trials list this drug (123 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06506292Phase 2 · recruiting A Phase II Trial of Perioperative Adebrelimab Combined With XELOX in Resectable Locally Advanced Gastric/Gastroesophageal Junction Cancer (GC/GEJC) · 148 trials list this drug (123 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06439589Phase 1/Phase 2 · unknown Phase Ib/II Study of HRS2398 in Combination With Adebrelimab in Patients With Advanced Solid Tumors · 148 trials list this drug (123 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04562337Phase 2 · unknown SHR-1316 Combined With Chemotherapy and Chest Radiotherapy in ES-SCLC · 148 trials list this drug (123 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06478264Phase 2 · not yet recruiting A Study of Adebrelimab Combined With Chemoradiotherapy in the Treatment of Esophageal Small Cell Carcinoma · 148 trials list this drug (123 active) | — | — | Esophageal Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06455410Phase 2 · recruiting GP Plus Adebrelimab Versus GP Neoadjuvant Chemotherapy for Nasopharyngeal Carcinoma · 148 trials list this drug (123 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06470633Phase 2 · not yet recruiting To Evaluate the Efficacy of Adebrelimab Combined With Chemotherapy After HIFU Induction Neoadjuvant Therapy HR+/HER2- Breast Cancer · 148 trials list this drug (123 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05444088Phase 1/Phase 2 · unknown Study of SHR-8068 Combined With Adebrelimab and Bevacizumab in the Treatment of Advanced Hepatocellular Carcinoma · 148 trials list this drug (123 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06464614Phase 2 · unknown Adebrelimab in Combination With Apatinib and Chemotherapy/Chemoradiotherapy in Immuno-experienced Second-line ESCC. · 148 trials list this drug (123 active) | — | — | Malignant Esophageal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06415669Phase 2 · recruiting A Study of Paclitaxel Combined With Apatinib and Adebrelimab in Gastric/Gastroesophageal Junction Adenocarcinoma · 148 trials list this drug (123 active) | — | — | Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06424899Phase 2 · recruiting A Study Comparing Neoadjuvant Chemoimmunotherapy and Immuno-consolidationafter Compared With Immunoconsolidation After Radical Chemoradiotherapy for Stage III Potentially Resectable NSCLC · 148 trials list this drug (123 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06385873Phase 2 · not yet recruiting RC48 Combined With Adebrelimab, Apatinib and S-1 as Neoadjuvant Therapy in Locally Advanced Gastric Cancer · 148 trials list this drug (123 active) | — | — | Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06181032Phase 1 · recruiting A Study of Adebrelimab in Combination With Apatinib Gemcitabine and Cisplatin in Biliary Tract Malignancies · 148 trials list this drug (123 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06389500Phase 2 · not yet recruiting HAIC+Adebrelimab+Lenvatinib for Conversion Treatment of Potentially Resectable, Locally Advanced Biliary Tract Cancer · 148 trials list this drug (123 active) | — | — | Malignant Biliary Tract Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06375642Phase 2 · unknown A Single Arm, Single Centered Phase II Trial on the Combination of Adebrelimab, Surufatinib and Irinotecan Liposome-based HAIC in Advanced iCC · 148 trials list this drug (123 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06373133Phase 1/Phase 2 · not yet recruiting SHR-8068 Combined With Adbelizumab and BP102 in the Treatment of Advanced Colorectal Cancer · 148 trials list this drug (123 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06296563Phase 2 · recruiting Perioperative Treatment of Resectable Intrahepatic Cholangiocarcinoma With the Combination of Adebrelimab and Apatinib and HAIC · 148 trials list this drug (123 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06149130Phase 2 · recruiting Adebrelimab Combined With Dalpiciclib and Standard Endocrine Therapy for HR+/HER2 - Advanced Breast Cancer · 148 trials list this drug (123 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06261125Phase 2 · recruiting Combination of SBRT, PD-L1 Inhibitor, and Lenvatinib in Hepatocellular Carcinoma (HSBRT2401) · 148 trials list this drug (123 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06306560Phase 2 · not yet recruiting A Study of Adebrelimab Combined With Famitinib and Chemotherapy in the Treatment of ES-SCLC. · 148 trials list this drug (123 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06299371Phase 2 · not yet recruiting Adebrelimab Plus Chemotherapy as Neoadjuvant Therapy in Resectable NSCLC Harboring Driver Gene Mutations · 148 trials list this drug (123 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06225921Phase 1 · unknown Neoadjuvant Adebrelimab With Dalpiciclib for Resectable Esophageal Squamous Cell Carcinomas · 148 trials list this drug (123 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06251492Phase 2 · unknown Radiation and Adebrelimab in Prostate Cancer With Imaging-measurable Disease (RAPID) · 148 trials list this drug (123 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06266832Phase 2 · recruiting The Efficacy and Safety of Short-course Radiation Combined With Adebrelimab and CAPEOX Neo-adjuvant Therapy for Organ-retention in Patients With MSS/pMMR Ultra Low Rectal Adenocarcinoma · 148 trials list this drug (123 active) | — | — | Rectal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06267170unknown A Multicenter, Real-world Study of Adebrelimab in the Treatment of Extensive Stage Small Cell Lung Cancer · 148 trials list this drug (123 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05205200Phase 2 · unknown Immune Therapy in HR-positive/HER2-negative Metastatic Breast Cancer(ENIGMA)-BCTOP-L-M02 · 148 trials list this drug (123 active) | — | — | Malignant Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05753826Phase 2 · recruiting Adebrelimab Combined With Fuzuloparib in the Treatment of Patients With Recurrent Platinum-resistant Ovarian Cancer. · 148 trials list this drug (123 active) | — | — | Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06236997Phase 2 · not yet recruiting Adebrelimab and Concurrent Radiochemotherapy as First-line Treatment for Extensive-stage Small-cell Lung Cancer · 148 trials list this drug (123 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06229067Phase 2 · not yet recruiting Efficacy and Safety of PD-L1 Monoclonal Antibody Combined With Metronomic VEX in Advanced Triple-negative Breast Cancer · 148 trials list this drug (123 active) | — | — | Malignant Breast Neoplasm,Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06177925Phase 2 · recruiting A Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLC · 148 trials list this drug (123 active) | — | — | Neoplasm,Neoplasm by Site,Respiratory System Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06156267early Phase 1 · not yet recruiting Study of Personalized Tumour Vaccines and a PD-L1 Blocker in Patients With Surgically Resected Pancreatic Adenocarcino · 148 trials list this drug (123 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06149767Phase 2 · not yet recruiting Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy in Cervical Cancer · 148 trials list this drug (123 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03995472Phase 1 · completed A Study of SHR-1501 Combined With SHR-1316 in Patients With Advanced Tumors · 148 trials list this drug (123 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05975463Phase 2 · unknown Hepatic Artery Infusion of Adebrelimab Combined With Bevacizumab in the Treatment of Advanced Hepatocellular Carcinoma With Failure of Systemic Therapy Combined With Interventional Therapy · 148 trials list this drug (123 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05942378Phase 1 · unknown A Study of HRXG-K-1939 and Adebrelimab in Patients With Advanced Solid Tumors · 148 trials list this drug (123 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05794477Phase 1/Phase 2 · unknown A Study of SHR-1802 in Combination With Adebrelimab in Patients With Advanced Solid Tumors · 148 trials list this drug (123 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03133247Phase 1 · completed A Trial to Evaluate Safety and Tolerability of SHR-1316 in Cancer Patients · 148 trials list this drug (123 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03711305Phase 3 · unknown Study of Carboplatin Plus Etoposide With or Without SHR-1316 in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC) · 148 trials list this drug (123 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04979390Phase 1 · unknown Safety, Tolerability and Pharmacokinetics of the New Formulation SHR-1316 in Subjects With Advanced Tumors · 148 trials list this drug (123 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04647357Phase 2 · unknown A Trial of SHR-1316 Maintenance Therapy for Limited Stage Small Cell Lung Cancer · 148 trials list this drug (123 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03732508Phase 2 · unknown SHR-1316 in Combination With Chemotherapy in Patients With Esophageal Squamous Cell Cancer · 148 trials list this drug (123 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03474289Phase 1 · unknown Safety and Tolerability of SHR-1316 in Subjects With Advanced Tumors · 148 trials list this drug (123 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |